VENUS II: THE SECOND US-BASED PHASE 3 STUDY OF ULIPRISTAL ACETATE (UPA) FOR TREATMENT OF SYMPTOMATIC UTERINE FIBROIDS (UF). Meeting Abstract

sustainable development goals

publication date

  • September 1, 2017

webpage

published in

start page

  • E27

end page

  • E28

volume

  • 108

issue

  • 3